Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.
Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Goto K, Kodama T, Eguchi K, Shinkai T, Tamura T, Ohe Y, Kunitoh H, Yoshimura K, Saijo N. Sekine I, et al. Among authors: kodama t. Br J Cancer. 2003 Mar 24;88(6):808-13. doi: 10.1038/sj.bjc.6600800. Br J Cancer. 2003. PMID: 12644814 Free PMC article. Clinical Trial.
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.
Goto K, Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Niho S, Kodama T, Shinkai T, Tamura T, Ohe Y, Kunitoh H, Yamamoto N, Nokihara H, Yoshida K, Sugiura T, Matsui K, Saijo N. Goto K, et al. Among authors: kodama t. Br J Cancer. 2004 Aug 16;91(4):659-65. doi: 10.1038/sj.bjc.6602056. Br J Cancer. 2004. PMID: 15280919 Free PMC article. Clinical Trial.
Second-line chemotherapy for relapsed small cell lung cancer.
Ebi N, Kubota K, Nishiwaki Y, Hojo F, Matsumoto T, Kakinuma R, Ohmatsu H, Sekine I, Yokosaki M, Gotoh K, Yamamoto H, Kodama T. Ebi N, et al. Among authors: kodama t. Jpn J Clin Oncol. 1997 Jun;27(3):166-9. doi: 10.1093/jjco/27.3.166. Jpn J Clin Oncol. 1997. PMID: 9255271 Clinical Trial.
Late recurrence of small-cell lung cancer: treatment and outcome.
Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Goto K, Kodama T. Sekine I, et al. Among authors: kodama t. Oncology. 1996 Jul-Aug;53(4):318-21. doi: 10.1159/000227580. Oncology. 1996. PMID: 8692537
Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.
Ando M, Eguchi K, Shinkai T, Tamura T, Ohe Y, Yamamoto N, Kurata T, Kasai T, Ohmatsu H, Kubota K, Sekine I, Hojo N, Matsumoto T, Kodama T, Kakinuma R, Nishiwaki Y, Saijo N. Ando M, et al. Among authors: kodama t. Br J Cancer. 1997;76(11):1494-9. doi: 10.1038/bjc.1997.584. Br J Cancer. 1997. PMID: 9400948 Free PMC article. Clinical Trial.
2,985 results